CompaniesHealthcare & FitnessPharmaceuticalsPrint articleBrief: Clinuvel PharmaceuticalsCorporate news snapshot for Clinuvel PharmaceuticalsDec 9, 2009 – 4.52pmSaveLog in or Subscribe to save articleShareCopy linkCopiedEmailLinkedInTwitterFacebookCopy linkCopiedShare via...Gift this articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? LoginClinuvel Pharmaceuticals (CUV) has obtained positive results from an experimental randomised placebo-controlled Phase II trial evaluating the photoprotective effect of afamelanotide in 16 patients.Loading...SaveLog in or Subscribe to save articleShareCopy linkCopiedEmailLinkedInTwitterFacebookCopy linkCopiedShare via...Gift this articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? LoginLicense articleIntroducing your NewsfeedFollow the topics, people and companies that matter to you.Find out moreRead MorePharmaceuticalsClinuvel PharmaceuticalsLatest In Healthcare & fitnessFetching latest articlesMost Viewed In Companies
